BackGlycoNex Incorporation Overview

GlycoNex Incorporation Total Assets

Track GlycoNex Incorporation's total assets ($1.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.39B
↑ 8.81% YoYΔ $112.65M vs prior year quarter

Peer trimmed avg / median

Loading

GlycoNex Incorporation Total Assets History

Loading

GlycoNex Incorporation vs. peers: Total Assets Comparison

Loading

GlycoNex Incorporation Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GlycoNex Incorporation (4168.TWO) FAQ

The latest total assets for 4168.TWO is $1.4B as of June 2026. That compares with $1.3B in the prior-year period — up 8.8% year over year. Investors often review this figure alongside GlycoNex Incorporation's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4168.TWO's total assets moved from $1.3B to $1.4B — a 8.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GlycoNex Incorporation's operating scale or balance-sheet position.

A total assets figure of $1.4B for 4168.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4168.TWO's total assets ($1.4B), review year-over-year change from $1.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GlycoNex Incorporation's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.